Due diligence services are constructed for companies seeking investment or strategic partnering, and also for the investment community. Bracken offers an integrated approach to due diligence projects, as they may require scientific, regulatory, or medical evaluation, as well as financial, strategic, and business evaluation. The team is pleased to collaborate with other experts or own the process entirely.
A critical component of drug development success is accessing adequate resources, both intellectual and financial, to bring a product from discovery to market. Financial institutions play a crucial role in successful drug development. These organizations are afforded numerous investment opportunities within healthcare for evaluation. Due diligence is an essential aspect of the investor’s decision-making process.
Bracken regularly undertakes due diligence at all stages of product development, and services include:
Successful drug development is a complex and costly process. Insightful integration of sound science and financial resources is essential. Our experienced biopharma consultants are qualified to assist both the development company and its financial partners throughout the entire process – helping to reduce investor and partner risk, while optimizing business strategy for on-time and on-budget product delivery.
Receive a collection of relevant, important articles and updates that inform our business conversations. Selected specifically for digital health and life science professionals, our newsletter is crafted with executives and team leaders in mind. Click here to preview, and subscribe below.
We would be delighted to hear from you and discuss our consulting services. Please call +1 215 648 1208 to chat with us directly. Or write to us using the form provided here. We look forward to collaborating with you.